Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BIO-TECHNE (TECH) EPS (Basic): 2009-2025

Historic EPS (Basic) for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $0.25.

  • BIO-TECHNE's EPS (Basic) rose 19.05% to $0.25 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.50, marking a year-over-year decrease of 47.37%. This contributed to the annual value of $0.47 for FY2025, which is 56.07% down from last year.
  • Latest data reveals that BIO-TECHNE reported EPS (Basic) of $0.25 as of Q3 2025, which was up 327.27% from -$0.11 recorded in Q2 2025.
  • BIO-TECHNE's 5-year EPS (Basic) high stood at $1.78 for Q3 2021, and its period low was -$2.33 during Q2 2021.
  • Its 3-year average for EPS (Basic) is $0.24, with a median of $0.25 in 2025.
  • Per our database at Business Quant, BIO-TECHNE's EPS (Basic) crashed by 251.30% in 2021 and then skyrocketed by 116.74% in 2022.
  • Over the past 5 years, BIO-TECHNE's EPS (Basic) (Quarterly) stood at $0.51 in 2021, then tumbled by 37.25% to $0.32 in 2022, then crashed by 46.88% to $0.17 in 2023, then rose by 29.41% to $0.22 in 2024, then grew by 19.05% to $0.25 in 2025.
  • Its last three reported values are $0.25 in Q3 2025, -$0.11 for Q2 2025, and $0.14 during Q1 2025.